- Home
- Primary Care
- MedX Weekly: FDA Approves First RNA-Targeted Therapy for Hereditary Angioedema, Updates COVID-19 Vaccines & More

4d2 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves First RNA-Targeted Therapy for Hereditary Angioedema The FDA has approved donidalorsen for preventing attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 and above. The RNA-targeted therapy reduces plasma
MedX Weekly: FDA Approves First RNA-Targeted Therapy for Hereditary Angioedema, Updates COVID-19 Vaccines & More
1588 Reached
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes